[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] BUKAVINA L,BENSALAH K,BRAY F,et al.Epidemiology of renal cell carcinoma:2022 update[J].Eur Urol,2022,82(5):529-542.
[3] CHEN LL.Linking long Noncoding RNA localization and function[J].Trends Biochem Sci,2016,41(9):761-772.
[4] ST LAURENT G,WAHLESTEDT C,KAPRANOV P.The landscape of long noncoding RNA classification[J].Trends Genet,2015,31(5):239-251.
[5] LIN W,ZHOU Q,WANG CQ,et al.LncRNAs regulate metabolism in cancer[J].Int J Biol Sci,2020,16(7):1194-1206.
[6] WINKLER L,DIMITROVA N.A mechanistic view of long noncoding RNAs in cancer[J].Wiley Interdiscip Rev RNA,2022,13(3):e1699.6.
[7]王海玲,李东霞.LncRNA与恶性肿瘤侵袭转移研究进展[J].现代肿瘤医学,2018,26(13):2114-2117.
WANG HL,LI DX.Advances in the research of LncRNA and invasion and metastasis of malignant tumor[J].Modern Oncology,2018,26(13):2114-2117.
[8] 何烨,王科明.长链非编码RNA在肿瘤中作用的研究及进展[J].现代肿瘤医学,2013,21(06):1381-1383.
HE Y,WANG KM.Research and progress on the role of long-chain non-coding RNA in cancer[J].Modern Oncology,2013,21(06):1381-1383.
[9] ZHENG R,BLOBEL GA,et al.GATA transcription factors and cancer[J].Genes & Cancer,2010,1(12):1178-1188.
[10] OHNEDA K,YAMAMOTO M.Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage[J].Acta Haematol,2002,108(4):237-245.
[11] ZHANG L,GAO L,SHAO M.A MYC target long non-coding RNA GATA2-AS1 regulates non-small cell lung cancer growth[J].Neoplasma,2019,66(6):954-962.
[12] LI Z,TAN H,YU H,et al.DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma[J].J Cell Biochem,2020,121(3):2406-2415.
[13] PAN Y,ZHU Y,ZHANG J,et al.A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation,invasion,epithelial-mesenchymal transition and stemness via recruiting DDX3X[J].J Transl Med,2022,20(1):287.
[14] NIU Y,GUO Y,LI Y,et al.LncRNA GATA2-AS1 suppresses esophageal squamous cell carcinoma progression via the miR-940/PTPN12 axis[J].Exp Cell Res,2022,416(2):113130.
[15] XU Q,DENG F,QIN Y,et al.Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis[J].Cell Death Dis,2016,7(6):e2254.
[16] ZHANG YP,CHENG YB,LI S,et al.An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma[J].Bioengineered,2021,12(1):555-564.
[17] MO S,ZHANG L,DAI W,et al.Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer[J].Cell Death Dis,2020,11(2):155.
[18] DASGUPTA P,KULKARNI P,MAJID S,et al.LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma[J].Cell Death Dis,2020,11(8):660.